Scott Wasserman reports a stock award at IKT
By AlphaYouPublished Form 4
Wasserman Scott M.
Reporting filer
Scott Wasserman reports a stock award, not an open-market purchase or sale, in Inhibikase Therapeutics, Inc.. Form 4 filed Oct 21, 2026 lists 1 entry.
- Disclosed
- Oct 21, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Wasserman Scott M. | 2026-10-19 | A | Grant or award | 310000 | 0 | 310,000 | 2 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Wasserman Scott M.
- Date
- 2026-10-19
- Code
- A
- Action
- Grant or award
- Quantity
- 310000
- Price
- 0
- Following holdings
- 310,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 1.645
- transaction Date: 2026-10-19
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 310000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-19
- underlying Security Title: Common Stock
- underlying Security Shares: 310000
- shares Owned Following Transaction: 310000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Wasserman Scott M.: Director.
- F1: The options will vest and become exercisable in equal annual installments over three years commencing from October 19, 2026, subject to the Reporting Person's continued service through each such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.